Nov 2 2009
ACM Global Central Laboratory, the global central lab that continually defines the customer-service standard with its flexible approach, is this week celebrating its 10th anniversary of providing central laboratory services throughout Europe. The company will be celebrating this landmark anniversary at the Partnerships in Clinical Trials Congress and Exhibition, Nov. 3-6 in Rotterdam, The Netherlands.
The European arm of ACM Global Central Laboratory, based in York, England, initiated as Pivotal Laboratories Limited in 1999 and since then has significantly expanded from a small scale operation to providing clinical trial services for some of the largest pharmaceutical, biotech companies and contract research organisations (CROs) across the globe.
Jerry Boxall, managing director of ACM Global Central Laboratory, Europe said, “We are delighted to be celebrating this milestone, and over the last 10 years have built up a solid reputation in the industry as a reliable global central laboratory that focuses on customer service, flexibility and precision. It is these core values, along with our dedicated team of industry experts and our global capabilities that has led to the company’s success.”
Reaching this milestone rounds off an excellent year for ACM Global Central Laboratory, Europe, who earlier in the year formalised their long-term partnership with ACM-Global Central Laboratory, based in Rochester, NY, and announced key appointments of Theresa Thackray, head of Business Development, Europe and Steve Morley, head of Operations, Europe to further strengthen their position in the industry.
“The Partnerships in Clinical Trials Congress and Exhibition is the perfect opportunity to celebrate this anniversary” said Elena Logan, VP of Global Clinical Trials. “It demonstrates our successful operation in Europe and we are committed to building on our impressive growth in this region.”
ACM Global Central Lab will be exhibiting at stand 41 at Partnerships in Clinical Trials Congress.
Ingestible capsule releases a burst of drugs directly into the walls of the GI tract